H. Lundbeck A/S (HLUBF)
6.40
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
H. Lundbeck Price to Book Value : 1.545 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 1.545 |
| October 02, 2026 | 1.545 |
| October 01, 2026 | 1.545 |
| September 30, 2026 | 1.545 |
| September 29, 2026 | 1.545 |
| September 28, 2026 | 1.545 |
| September 25, 2026 | 1.545 |
| September 24, 2026 | 1.545 |
| September 23, 2026 | 1.545 |
| September 22, 2026 | 1.545 |
| September 21, 2026 | 1.545 |
| September 18, 2026 | 1.545 |
| September 17, 2026 | 1.545 |
| September 16, 2026 | 1.545 |
| September 15, 2026 | 1.545 |
| September 14, 2026 | 1.639 |
| September 11, 2026 | 1.584 |
| September 10, 2026 | 1.338 |
| September 09, 2026 | 1.338 |
| September 08, 2026 | 1.338 |
| September 04, 2026 | 1.338 |
| September 03, 2026 | 1.338 |
| September 02, 2026 | 1.338 |
| September 01, 2026 | 1.338 |
| August 31, 2026 | 1.338 |
| Date | Value |
|---|---|
| August 28, 2026 | 1.338 |
| August 27, 2026 | 1.338 |
| August 26, 2026 | 1.338 |
| August 25, 2026 | 1.338 |
| August 24, 2026 | 1.338 |
| August 21, 2026 | 1.338 |
| August 20, 2026 | 1.338 |
| August 19, 2026 | 1.338 |
| August 18, 2026 | 1.338 |
| August 17, 2026 | 1.338 |
| August 14, 2026 | 1.338 |
| August 13, 2026 | 1.311 |
| August 12, 2026 | 1.311 |
| August 11, 2026 | 1.311 |
| August 10, 2026 | 1.311 |
| August 07, 2026 | 1.311 |
| August 06, 2026 | 1.311 |
| August 05, 2026 | 1.311 |
| August 04, 2026 | 1.318 |
| August 03, 2026 | 1.318 |
| July 31, 2026 | 1.318 |
| July 30, 2026 | 1.318 |
| July 29, 2026 | 1.318 |
| July 28, 2026 | 1.318 |
| July 27, 2026 | 1.318 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novo Nordisk A/S | 4.902 |
| ALK-Abello A/S | 6.478 |
| AstraZeneca PLC | 10.39 |
| ANI Pharmaceuticals, Inc. | 2.752 |
| Corcept Therapeutics, Inc. | 18.29 |
Price to Book Value Related Metrics
| PE Ratio | 10.47 |
| PS Ratio | 1.585 |
| PEG Ratio | 0.4929 |
| Price to Free Cash Flow | 8.817 |
| Price | 6.40 |
| Earnings Yield | 9.55% |
| Market Cap | 6.350B |
| PEGY Ratio | 0.4343 |
| Operating PE Ratio | 5.818 |
| Normalized PE Ratio | 8.837 |